Research may provide gluten exposure safety net

02/27/2013 | U.S. News & World Report

Ongoing studies may yield treatments that make gluten less toxic to people with celiac disease or those who are gluten sensitive, says dietitian Tamara Duker Freuman. Researchers are testing larazotide acetate as a way to block a reaction if small amounts of gluten are unintentionally consumed, along with enzyme therapies that could disarm gluten before it harms the digestive system.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA